Editorial - Fentanyl in the US heroin supply: A rapidly changing risk environment

From the Special Edition of the International Journal of Drug Policy: US Heroin in Transition: Supply Changes, Fentanyl Adulteration and Consequences, August 2017, Volume 46, pp 107-111.

Abstract

From Ebola to Heroin; the Use of EMS Data for Near Real Time Alerting and Surviellance

Arguably the two most significant public health issues over the past two years have been the outbreak of ebola in West Africa and the rising epidemic of heroin use and overdoses. In the case of Ebola, the CDC issued guidance for inpatient facilities to screen for potential cases, however, there was little guidance for screening patients that presented to EMS workers. The West African pateint aht presented to the Emergency Department in Dallas was transported, unknowingly, by EMS, potentially exposing them and others to this deadly disease.

CDC June Community of Practice Webinar

Drs. Arens, Vo, van Wijk, and Coffin will present a cluster of opioid-related poisoning cases and deaths in San Francisco following ingestion of counterfeit pills designed to look like prescription medication. They will describe the clinical cases and detailed the coordinated public health response, which included the local PCC, a toxicology lab, a public health officer, the local medical examiner, and affected hospitals.

Presenters 

Characterizing Fentanyl-Associated Mortality using the Literal Causes of Death

In October 2015, the Centers for Disease Control and Prevention (CDC) released health advisory #384 to inform people about increases in fentanyl fatalities. Florida’s statewide syndromic surveillance system, Electronic Surveillance System for the Early Notification of Community-based Epidemics (ESSENCE-FL), captures electronic death record data in near real time which allows for the monitoring of mortality trends across the state.

Opioid Surveillance Webinar Series #3 Part 2: Drug Overdose Surveillance in Florida Using Death Record, Poison Control, and Emergency Department Data

This is the second part of the third installment of the ISDS Opioid Surveillance Webinar Series, held on July 27, 2017. Part 2 starts at 44:32.

This presentation will focus on using multiple data sources housed within Florida’s syndromic surveillance system to monitor drug overdoses within the state.

Presenter: 

David Atrubin, MPH , Surveillance Epidemiologist , Florida Department of Health 

Opioid Surveillance Webinar Series #3 Part 1: Syndromic Surveillance Case Definition for Monitoring Opioid Related ED visits in the Colorado North Central Region (CO-NCR), State of Nebraska, and Marion County, Indiana

This is the first part of the third installment of the ISDS Opioid Surveillance Webinar Series, held on July 27, 2017.

The goal of this ongoing collaboration is to work together to develop a standard case definition for opioid abuse/poisoning, which would then be applicable in multiple jurisdictions.

Opioid Surveillance Webinar Series #2: Challenges and Implications of Postmarketing Surveillance of Prescription Opioids

The presentation will address the unique challenges of surveillance or prescription opioid abuse and present data from multiple perspectives on the issues and potential solution.

Presenter

Richard Dart, MD, PhD 
Director, Rocky Mountain Poison and Drug Center 
Executive Director, RADARS System 
Professor, University of Colorado Health Sciences Center 

Opioid Surveillance Webinar Series #1: Rapid surveillance of overdose morbidity - Developing case definitions, building queries, and analyzing results

This is the first of a series of three webinars presented for the ISDS Opioid Surveillance Webinar Series, June - July 2017.

This presentation describes how CDC has partnered with states to develop case definitions for all drug, opioid, and heroin within and outside of the NSSP/ESSENCE system. The presenters also share lessons learned and things to consider for the rapid surveillance of opioid overdose.

Presenters

R. Matthew Gladden, PhD, Division of Unintentional Injury Prevention, CDC 

Builiding Methods for a Proactive Prescription Drug Surveillance System

Prescription Drug Monitoring Programs (PDMPs) are operating in 49 states and several U.S. territories.

Legal Interventions to Reduce Overdose Mortality: Naloxone Access and Overdose Good Samaritan Laws

This resource, developed by the Network for Public Health Law and released on June 8, 2017, summarizes state naloxone access and Good Samaritan laws.

Background

Pages

Contact Us

INTERNATIONAL SOCIETY FOR
DISEASE SURVEILLANCE

288 Grove Street, Box 203
Braintree, MA 02184
(617) 779 0880
Email:syndromic@syndromic.org

This Knowledge Repository is made possible through the activities of the Centers for Disease Control and Prevention Cooperative Agreement/Grant #1 NU500E000098-01, National Surveillance Program Community of Practice (NSSP-CoP): Strengthening Health Surveillance Capabilities Nationwide, which is in the interest of public health.